General Information of Drug Transporter (DT)
DT ID DTD0240 Transporter Info
Gene Name SLC27A3
Transporter Name Long-chain fatty acid transport protein 3
Gene ID
11000
UniProt ID
Q5K4L6
Epigenetic Regulations of This DT (EGR)

Methylation

  Prostate cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in prostate cancer [ 1 ]

Location

5'UTR (cg12662091)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.18E+00 Statistic Test p-value:3.76E-02; Z-score:1.97E+00

Methylation in Case

9.53E-02 (Median) Methylation in Control 8.04E-02 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in prostate cancer [ 1 ]

Location

TSS1500 (cg17243364)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.28E+00 Statistic Test p-value:9.03E-03; Z-score:-3.15E+00

Methylation in Case

1.30E-01 (Median) Methylation in Control 1.66E-01 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in prostate cancer [ 1 ]

Location

TSS1500 (cg13818276)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.15E+00 Statistic Test p-value:3.03E-02; Z-score:3.35E+00

Methylation in Case

8.39E-01 (Median) Methylation in Control 7.27E-01 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in prostate cancer [ 1 ]

Location

Body (cg19377250)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.52E+00 Statistic Test p-value:1.88E-03; Z-score:6.25E+00

Methylation in Case

8.23E-01 (Median) Methylation in Control 5.41E-01 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC27A3 in prostate cancer [ 1 ]

Location

Body (cg11640015)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.24E+00 Statistic Test p-value:5.34E-03; Z-score:2.32E+00

Methylation in Case

8.23E-01 (Median) Methylation in Control 6.61E-01 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Bladder cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in bladder cancer [ 2 ]

Location

TSS1500 (cg00421624)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.28E+00 Statistic Test p-value:3.16E-03; Z-score:2.42E+00

Methylation in Case

7.43E-01 (Median) Methylation in Control 5.80E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in bladder cancer [ 2 ]

Location

TSS1500 (cg26904702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.08E+00 Statistic Test p-value:2.33E-02; Z-score:1.08E+00

Methylation in Case

6.79E-01 (Median) Methylation in Control 6.30E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in bladder cancer [ 2 ]

Location

TSS200 (cg05784314)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.37E+00 Statistic Test p-value:2.93E-02; Z-score:1.62E+00

Methylation in Case

4.46E-02 (Median) Methylation in Control 3.27E-02 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in bladder cancer [ 2 ]

Location

TSS200 (cg19773045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.69E+00 Statistic Test p-value:3.53E-02; Z-score:-3.27E+00

Methylation in Case

1.40E-01 (Median) Methylation in Control 2.38E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC27A3 in bladder cancer [ 2 ]

Location

3'UTR (cg11804721)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.29E+00 Statistic Test p-value:5.00E-06; Z-score:-1.21E+01

Methylation in Case

4.27E-01 (Median) Methylation in Control 5.52E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Breast cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

TSS1500 (cg26904702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.62E+00 Statistic Test p-value:7.34E-32; Z-score:4.88E+00

Methylation in Case

6.60E-01 (Median) Methylation in Control 4.08E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

TSS1500 (cg03138446)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.23E+00 Statistic Test p-value:2.88E-18; Z-score:2.54E+00

Methylation in Case

8.04E-01 (Median) Methylation in Control 6.55E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

TSS1500 (cg00421624)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.56E+00 Statistic Test p-value:8.78E-15; Z-score:3.13E+00

Methylation in Case

6.74E-01 (Median) Methylation in Control 4.33E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

TSS1500 (cg21279955)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.68E+00 Statistic Test p-value:1.25E-09; Z-score:2.90E+00

Methylation in Case

2.33E-01 (Median) Methylation in Control 1.39E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

TSS200 (cg24408896)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.43E+00 Statistic Test p-value:1.01E-07; Z-score:1.46E+00

Methylation in Case

1.49E-01 (Median) Methylation in Control 1.04E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

TSS200 (cg19773045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.68E+00 Statistic Test p-value:1.40E-07; Z-score:2.30E+00

Methylation in Case

2.70E-01 (Median) Methylation in Control 1.61E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

TSS200 (cg06239526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.59E+00 Statistic Test p-value:3.10E-06; Z-score:1.56E+00

Methylation in Case

1.50E-01 (Median) Methylation in Control 9.43E-02 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

TSS200 (cg16247817)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.65E+00 Statistic Test p-value:6.24E-06; Z-score:1.41E+00

Methylation in Case

5.43E-02 (Median) Methylation in Control 3.28E-02 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

TSS200 (cg05784314)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.44E+00 Statistic Test p-value:3.42E-02; Z-score:3.65E-01

Methylation in Case

4.21E-02 (Median) Methylation in Control 2.92E-02 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC27A3 in breast cancer [ 3 ]

Location

Body (cg15930240)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.24E+00 Statistic Test p-value:5.67E-09; Z-score:1.84E+00

Methylation in Case

7.00E-01 (Median) Methylation in Control 5.63E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg21279955)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.64E+00 Statistic Test p-value:4.48E-05; Z-score:1.13E+00

Methylation in Case

1.92E-01 (Median) Methylation in Control 1.17E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg26904702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.03E+00 Statistic Test p-value:9.50E-03; Z-score:7.34E-01

Methylation in Case

7.80E-01 (Median) Methylation in Control 7.56E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in clear cell renal cell carcinoma [ 4 ]

Location

TSS200 (cg19773045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.86E+00 Statistic Test p-value:5.43E-06; Z-score:1.46E+00

Methylation in Case

2.61E-01 (Median) Methylation in Control 1.40E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in clear cell renal cell carcinoma [ 4 ]

Location

TSS200 (cg24408896)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.93E+00 Statistic Test p-value:3.40E-04; Z-score:1.03E+00

Methylation in Case

1.56E-01 (Median) Methylation in Control 8.08E-02 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Colorectal cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in colorectal cancer [ 5 ]

Location

TSS1500 (cg03138446)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:3.01E-02; Z-score:-4.39E-01

Methylation in Case

9.33E-01 (Median) Methylation in Control 9.41E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in colorectal cancer [ 5 ]

Location

1stExon (cg06089988)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.22E+00 Statistic Test p-value:5.34E-05; Z-score:1.54E+00

Methylation in Case

9.60E-02 (Median) Methylation in Control 7.86E-02 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in colorectal cancer [ 5 ]

Location

1stExon (cg07246449)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.15E+00 Statistic Test p-value:1.60E-04; Z-score:1.19E+00

Methylation in Case

8.15E-02 (Median) Methylation in Control 7.10E-02 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in colorectal cancer [ 5 ]

Location

1stExon (cg23376526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.20E+00 Statistic Test p-value:9.81E-04; Z-score:1.15E+00

Methylation in Case

9.70E-02 (Median) Methylation in Control 8.10E-02 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC27A3 in colorectal cancer [ 5 ]

Location

3'UTR (cg11804721)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.14E+00 Statistic Test p-value:1.58E-03; Z-score:-1.07E+00

Methylation in Case

6.35E-01 (Median) Methylation in Control 7.21E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

         15 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

TSS1500 (cg03138446)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.03E+00 Statistic Test p-value:5.17E-08; Z-score:-1.17E+00

Methylation in Case

8.26E-01 (Median) Methylation in Control 8.49E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

TSS1500 (cg00421624)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.09E+00 Statistic Test p-value:2.02E-07; Z-score:1.50E+00

Methylation in Case

7.77E-01 (Median) Methylation in Control 7.12E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

TSS1500 (cg21279955)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.44E+00 Statistic Test p-value:1.04E-06; Z-score:-1.26E+00

Methylation in Case

1.55E-01 (Median) Methylation in Control 2.23E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

TSS1500 (cg26904702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.04E+00 Statistic Test p-value:2.16E-05; Z-score:-1.10E+00

Methylation in Case

7.09E-01 (Median) Methylation in Control 7.38E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

TSS200 (cg19773045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.45E+00 Statistic Test p-value:1.22E-08; Z-score:-1.36E+00

Methylation in Case

1.95E-01 (Median) Methylation in Control 2.82E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

TSS200 (cg06239526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.66E+00 Statistic Test p-value:1.21E-06; Z-score:-1.22E+00

Methylation in Case

1.11E-01 (Median) Methylation in Control 1.85E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

TSS200 (cg24408896)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.31E+00 Statistic Test p-value:9.56E-04; Z-score:-7.91E-01

Methylation in Case

1.29E-01 (Median) Methylation in Control 1.69E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

TSS200 (cg16247817)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.36E+00 Statistic Test p-value:1.39E-02; Z-score:-6.80E-01

Methylation in Case

5.53E-02 (Median) Methylation in Control 7.50E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

Body (cg01841415)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.44E+00 Statistic Test p-value:2.09E-18; Z-score:-5.43E+00

Methylation in Case

4.81E-01 (Median) Methylation in Control 6.93E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

Body (cg03364832)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.74E+00 Statistic Test p-value:4.31E-18; Z-score:-3.80E+00

Methylation in Case

3.79E-01 (Median) Methylation in Control 6.59E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon11

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

Body (cg22985016)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.94E+00 Statistic Test p-value:1.53E-17; Z-score:-2.95E+00

Methylation in Case

3.69E-01 (Median) Methylation in Control 7.17E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon12

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

Body (cg25368728)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.41E+00 Statistic Test p-value:2.88E-14; Z-score:-2.92E+00

Methylation in Case

5.11E-01 (Median) Methylation in Control 7.20E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon13

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

Body (cg00502885)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.39E+00 Statistic Test p-value:1.33E-11; Z-score:-4.09E+00

Methylation in Case

5.66E-01 (Median) Methylation in Control 7.84E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon14

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

Body (cg23701033)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.35E+00 Statistic Test p-value:6.16E-10; Z-score:-1.88E+00

Methylation in Case

3.67E-01 (Median) Methylation in Control 4.94E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon15

Methylation of SLC27A3 in hepatocellular carcinoma [ 6 ]

Location

3'UTR (cg16392193)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.51E+00 Statistic Test p-value:1.92E-17; Z-score:-3.83E+00

Methylation in Case

2.72E-01 (Median) Methylation in Control 4.12E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in lung adenocarcinoma [ 7 ]

Location

TSS1500 (cg00421624)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.17E+00 Statistic Test p-value:2.82E-04; Z-score:2.10E+00

Methylation in Case

7.08E-01 (Median) Methylation in Control 6.08E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in lung adenocarcinoma [ 7 ]

Location

TSS1500 (cg21279955)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.34E+00 Statistic Test p-value:3.82E-03; Z-score:2.53E+00

Methylation in Case

3.74E-01 (Median) Methylation in Control 2.78E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in lung adenocarcinoma [ 7 ]

Location

TSS1500 (cg26904702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.04E+00 Statistic Test p-value:1.36E-02; Z-score:1.01E+00

Methylation in Case

7.88E-01 (Median) Methylation in Control 7.58E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in lung adenocarcinoma [ 7 ]

Location

TSS200 (cg16247817)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.55E+00 Statistic Test p-value:4.21E-05; Z-score:2.50E+00

Methylation in Case

1.39E-01 (Median) Methylation in Control 8.95E-02 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC27A3 in lung adenocarcinoma [ 7 ]

Location

TSS200 (cg24408896)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.42E+00 Statistic Test p-value:4.27E-03; Z-score:2.26E+00

Methylation in Case

3.28E-01 (Median) Methylation in Control 2.31E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC27A3 in lung adenocarcinoma [ 7 ]

Location

TSS200 (cg19773045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.26E+00 Statistic Test p-value:5.20E-03; Z-score:1.59E+00

Methylation in Case

4.11E-01 (Median) Methylation in Control 3.27E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC27A3 in lung adenocarcinoma [ 7 ]

Location

TSS200 (cg06239526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.33E+00 Statistic Test p-value:5.30E-03; Z-score:1.60E+00

Methylation in Case

3.16E-01 (Median) Methylation in Control 2.37E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC27A3 in lung adenocarcinoma [ 7 ]

Location

TSS200 (cg05784314)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.28E+00 Statistic Test p-value:2.90E-02; Z-score:2.64E+00

Methylation in Case

1.00E-01 (Median) Methylation in Control 7.82E-02 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC27A3 in lung adenocarcinoma [ 7 ]

Location

Body (cg15930240)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.12E+00 Statistic Test p-value:4.50E-02; Z-score:2.87E+00

Methylation in Case

7.85E-01 (Median) Methylation in Control 7.02E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in pancretic ductal adenocarcinoma [ 8 ]

Location

TSS1500 (cg07748193)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:3.44E-02; Z-score:-4.65E-01

Methylation in Case

5.59E-01 (Median) Methylation in Control 5.69E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in pancretic ductal adenocarcinoma [ 8 ]

Location

Body (cg04590638)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.31E+00 Statistic Test p-value:3.81E-28; Z-score:-3.74E+00

Methylation in Case

5.47E-01 (Median) Methylation in Control 7.16E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in pancretic ductal adenocarcinoma [ 8 ]

Location

Body (cg15164708)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.25E+00 Statistic Test p-value:3.87E-23; Z-score:3.18E+00

Methylation in Case

5.08E-01 (Median) Methylation in Control 4.06E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in pancretic ductal adenocarcinoma [ 8 ]

Location

Body (cg04310063)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.09E+00 Statistic Test p-value:2.48E-11; Z-score:-1.55E+00

Methylation in Case

7.18E-01 (Median) Methylation in Control 7.82E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC27A3 in pancretic ductal adenocarcinoma [ 8 ]

Location

Body (cg07566700)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.08E+00 Statistic Test p-value:5.04E-10; Z-score:-1.56E+00

Methylation in Case

7.56E-01 (Median) Methylation in Control 8.19E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC27A3 in pancretic ductal adenocarcinoma [ 8 ]

Location

Body (cg14673267)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.03E+00 Statistic Test p-value:1.46E-02; Z-score:5.31E-01

Methylation in Case

9.09E-01 (Median) Methylation in Control 8.82E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC27A3 in pancretic ductal adenocarcinoma [ 8 ]

Location

Body (cg07562926)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.02E+00 Statistic Test p-value:2.74E-02; Z-score:4.75E-01

Methylation in Case

7.37E-01 (Median) Methylation in Control 7.22E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Panic disorder

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in panic disorder [ 9 ]

Location

TSS1500 (cg00421624)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-8.99E-01 Statistic Test p-value:7.80E-03; Z-score:-3.70E-01

Methylation in Case

-1.66E+00 (Median) Methylation in Control -1.49E+00 (Median)

Studied Phenotype

Panic disorder[ ICD-11:6B01]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

TSS1500 (cg03138446)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.06E+00 Statistic Test p-value:1.10E-11; Z-score:1.50E+00

Methylation in Case

8.70E-01 (Median) Methylation in Control 8.22E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

TSS1500 (cg26904702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.09E+00 Statistic Test p-value:4.53E-07; Z-score:1.34E+00

Methylation in Case

7.71E-01 (Median) Methylation in Control 7.08E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

TSS1500 (cg21279955)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.22E+00 Statistic Test p-value:4.44E-03; Z-score:6.68E-01

Methylation in Case

1.70E-01 (Median) Methylation in Control 1.38E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

TSS1500 (cg00421624)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.05E+00 Statistic Test p-value:9.40E-03; Z-score:7.45E-01

Methylation in Case

8.00E-01 (Median) Methylation in Control 7.65E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

TSS200 (cg19773045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.37E+00 Statistic Test p-value:1.75E-03; Z-score:8.45E-01

Methylation in Case

2.01E-01 (Median) Methylation in Control 1.47E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

TSS200 (cg06239526)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.63E+00 Statistic Test p-value:2.14E-03; Z-score:8.60E-01

Methylation in Case

1.03E-01 (Median) Methylation in Control 6.35E-02 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

TSS200 (cg16247817)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.05E+00 Statistic Test p-value:3.28E-02; Z-score:2.20E-01

Methylation in Case

8.49E-02 (Median) Methylation in Control 8.08E-02 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

1stExon (cg06089988)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.07E+00 Statistic Test p-value:6.74E-03; Z-score:-6.84E-01

Methylation in Case

8.25E-02 (Median) Methylation in Control 8.84E-02 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

1stExon (cg18163252)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.04E+00 Statistic Test p-value:3.73E-02; Z-score:-2.71E-01

Methylation in Case

4.42E-02 (Median) Methylation in Control 4.58E-02 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC27A3 in papillary thyroid cancer [ 10 ]

Location

3'UTR (cg11804721)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.33E+00 Statistic Test p-value:3.44E-12; Z-score:-1.92E+00

Methylation in Case

4.14E-01 (Median) Methylation in Control 5.53E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Colon cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC27A3 in colon adenocarcinoma [ 11 ]

Location

Body (cg23968154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.35E+00 Statistic Test p-value:4.37E-06; Z-score:-2.09E+00

Methylation in Case

4.94E-01 (Median) Methylation in Control 6.65E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC27A3 in colon adenocarcinoma [ 11 ]

Location

Body (cg17805836)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.13E+00 Statistic Test p-value:1.98E-05; Z-score:-4.34E+00

Methylation in Case

7.82E-01 (Median) Methylation in Control 8.83E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC27A3 in colon adenocarcinoma [ 11 ]

Location

Body (cg17298751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.11E+00 Statistic Test p-value:8.23E-05; Z-score:1.22E+00

Methylation in Case

7.50E-01 (Median) Methylation in Control 6.77E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC27A3 in colon adenocarcinoma [ 11 ]

Location

Body (cg12082025)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.38E+00 Statistic Test p-value:1.45E-03; Z-score:-1.53E+00

Methylation in Case

5.71E-01 (Median) Methylation in Control 7.87E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples
References
1 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
5 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
6 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
7 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
8 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
9 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
10 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
11 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.